| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| 13-cis-retinoic acid for chemoprevention after colpoconization for cervicalintraepithelial neoplasia |
Kim, S.H.;Park, T.K.;Kwon, J.Y.; |
International Journal of Gynecology & Obstetrics |
2003-05-01 |
查看 |
| The cyclooxygenase-2 inhibitor rofecoxib (Vioxx^(R)) in the treatmentof cervical dysplasia grade II-III |
Hefler, L.A.;Grimm, C.;Speiser, P.;Sliutz, G.;Reinthaller, A.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2006-04-01 |
查看 |
| The cyclooxygenase-2 inhibitor rofecoxib (Vioxx^(R)) in the treatmentof cervical dysplasia grade II-III |
Hefler, L.A.;Grimm, C.;Speiser, P.;Sliutz, G.;Reinthaller, A.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2006-04-01 |
查看 |
| The effect of lifestyle factors on gynaecological cancer |
Rieck, G.;Fiander, A.; |
Best Practice & Research in Clinical Obstetrics and Gynaecology |
2006-04-01 |
查看 |
| Chemoprevention of cervical cancer |
Sasieni, P.; |
Best Practice & Research in Clinical Obstetrics and Gynaecology |
2006-04-01 |
查看 |
| Clinical cancer chemoprevention: From the hepatitis B virus (HBV)vaccine to the human papillomavirus (HPV) vaccine |
Tsai, H.J.; |
Taiwanese Journal of Obstetrics and Gynecology |
2015-04-01 |
查看 |
|
|
